FIELD: medicine.
SUBSTANCE: invention refers to medicine and can be used for treating nosocomial infectious pneumonia in a patient. That is ensured by administering an effective amount of a combination of ceftazydime or its pharmaceutically acceptable salt and avibactam or its pharmaceutically acceptable salt. An effective amount of ceftazidime is 2000 mg and an effective amount of avibactam is 500 mg per dose. Said combination is introduced intravenously every eight hours.
EFFECT: invention provides treating nosocomial infectious pneumonia in a patient.
6 cl, 14 dwg, 5 ex, 18 tbl
| Title |
Year |
Author |
Number |
| PHARMACEUTICAL COMPOSITION FOR TREATING BACTERIAL INFECTIONS CAUSED BY THE MAIN PATHOGENS |
2023 |
- Sidorov Stanislav Mikhailovich
- Prokopenko Dmitrii Olegovich
|
RU2825961C1 |
| AGENT FOR THE TREATMENT OF INFECTIONS CAUSED BY MULTI-RESISTANT BACTERIA, INCLUDING THOSE PRODUCING CARBAPENEMASE |
2022 |
- Sidorenko Sergej Vladimirovich
- Yudin Sergej Mikhajlovich
- Yakovlev Sergej Vladimirovich
- Sidorov Stanislav Mikhajlovich
- Prokopenko Dmitrij Olegovich
|
RU2793587C1 |
| ORALLY ADMINISTERED COMBINATIONS OF BETA-LACTAM ANTIBIOTICS AND AVIBACTAM DERIVATIVES FOR TREATING BACTERIAL INFECTIONS |
2020 |
- Trias, Joakim
- Sejbl, Kerol
- Nikolls, Endryu
|
RU2825281C1 |
| PHARMACEUTICAL COMPOSITION OF 4-(3-ETHOXY-4-HYDROXYBENZYL)-5-OXO-5,6-DIHYDRO-4H-[1,3,4]-THIADIAZIN-2-(2,4-DIFLUOROPHENYL) CARBOXAMIDE IN CRYSTALLINE FORM , AND USE THEREOF AS ANTIBACTERIAL AGENT FOR TREATING ACUTE, RECURRENT AND CHRONIC INFECTIONS |
2020 |
- Zigangirova Nailia Akhatovna
- Lubenets Nadezhda Leonidovna
- Zaiakin Egor Sergeevich
- Luiksaar Sergei Igorevich
- Sheremet Anna Borisovna
- Soloveva Anna Vladimirovna
- Gintsburg Aleksandr Leonidovich
|
RU2737087C1 |
| CEFTAROLINE-INCLUDING COMPOSITIONS AND METHODS OF TREATMENT |
2009 |
|
RU2524665C2 |
| ALGINATE OLIGOMERS APPLICABLE IN OVERCOMING MULTIPLE DRUG RESISTANCE IN BACTERIA |
2010 |
- Onsoyen Edvar
- Myrvold Rolf
- Dessen Arne
- Thomas David
- Walsh Timothy
|
RU2582938C2 |
| IDENTIFICATION OF LYSINES AND THEIR DERIVATIVES WITH ANTIBACTERIAL ACTIVITY AGAINST PSEUDOMONAS AERUGINOSA |
2018 |
- Shukh, Rejmond
- Indiani, Kiara
|
RU2807688C2 |
| NEW Β-LACTAMASE INHIBITORS |
2017 |
- Khu, Boyuj
- Din, Charlz Z.
- Khuan, Chzhigan
- Lin, Zhujbin
- Syao, Minlyan
- Se, Tszinshen
- Chen, Shukhuej
- Li, Chen
|
RU2741963C2 |
| METHODS OF TREATING BACTERIAL INFECTIONS |
2014 |
- Pejdzh Stefen
- Garg Sandzhaj
|
RU2666605C2 |
| SOLID DISPERSION of 4- (3-ETHOXY-4-HYDROXIBENZIL) -5-OXO-5,6-DIHYDRO-4H- [1,3,4] -THIADIAZINE-2- (2,4-DIFLUOROPHENYL) -CARBOXAMIDE FOR PRODUCING PHARMACEUTICAL FORMULATION AND METHOD OF TREATMENT OF CHRONIC INFECTIOUS DISEASES |
2020 |
- Zigangirova Nailia Akhatovna
- Lubenets Nadezhda Leonidovna
- Zolotov Sergei Anatolevich
- Luiksaar Sergei Igorevich
- Zaiakin Egor Sergeevich
- Zakhoda Oleg Iurevich
- Sheremet Anna Borisovna
- Soloveva Anna Vladimirovna
- Gintsburg Aleksandr Leonidovich
|
RU2743927C1 |
